[DOI: 10.1371/journal.pone.0028268 LK - [DOI] [PMC free article] [PubMed] [Google Scholar] 23.Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, DiR Karnad, Kleinpell RM, Koh Y, Lisboa TC, MacHado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van Der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP
Melatonin protects ADSCs from ROS and enhances their therapeutic potency in a rat model of myocardial infarction
The peptide does not appear to interact with cytochrome P450 enzymes, suggesting low potential for drug interactions
Read safety information Supporting research A selection of peer-reviewed work on AOD 9604/MOTS-C